4//SEC Filing
Treco Douglas A 4
Accession 0000950170-24-031877
CIK 0001693011other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 8:30 AM ET
Size
5.3 KB
Accession
0000950170-24-031877
Insider Transaction Report
Form 4
Treco Douglas A
DirectorCEO & Chairman
Transactions
- Award
Stock Option (right to buy)
2024-03-13+300,000→ 300,000 totalExercise: $5.77Exp: 2034-03-12→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 13, 2024 and is scheduled to vest in equal monthly installments until the fourth anniversary of the grant date.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001688192
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 8:30 AM ET
- Size
- 5.3 KB